BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28164722)

  • 21. Follicular lymphoma: 2012 update on diagnosis and management.
    Freedman A
    Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How I treat early-relapsing follicular lymphoma.
    Casulo C; Barr PM
    Blood; 2019 Apr; 133(14):1540-1547. PubMed ID: 30700421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.
    Sebban C; Brice P; Delarue R; Haioun C; Souleau B; Mounier N; Brousse N; Feugier P; Tilly H; Solal-CĂ©ligny P; Coiffier B
    J Clin Oncol; 2008 Jul; 26(21):3614-20. PubMed ID: 18559872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transformed follicular lymphoma.
    Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
    Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicular lymphoma: 2014 update on diagnosis and management.
    Freedman A
    Am J Hematol; 2014 Apr; 89(4):429-36. PubMed ID: 24687887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How I manage patients with follicular lymphoma.
    Casulo C
    Br J Haematol; 2019 Aug; 186(4):513-523. PubMed ID: 31173345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissecting follicular lymphoma: high versus low risk.
    Smith SM
    Hematology Am Soc Hematol Educ Program; 2013; 2013():561-7. PubMed ID: 24319232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to manage early-stage follicular lymphoma.
    Cencini E; Fabbri A; Mecacci B; Bocchia M
    Expert Rev Hematol; 2020 Oct; 13(10):1093-1105. PubMed ID: 32869685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular lymphoma grade 3: review and updates.
    Vaidyanathan G; Czuczman MS
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):431-5. PubMed ID: 25066038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From genetics to the clinic: a translational perspective on follicular lymphoma.
    Huet S; Sujobert P; Salles G
    Nat Rev Cancer; 2018 Apr; 18(4):224-239. PubMed ID: 29422597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.
    Vidal L; Gafter-Gvili A; Leibovici L; Dreyling M; Ghielmini M; Hsu Schmitz SF; Cohen A; Shpilberg O
    J Natl Cancer Inst; 2009 Feb; 101(4):248-55. PubMed ID: 19211444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Agents Beyond Immunomodulatory Agents and Phosphoinositide-3-Kinase for Follicular Lymphoma.
    Chin CK; Nastoupil LJ
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):743-756. PubMed ID: 32586578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follicular lymphoma: Update on management and emerging therapies at the dawn of the new decade.
    Apostolidis J; Mokhtar N; Al Omari R; Darweesh M; Al Hashmi H
    Hematol Oncol; 2020 Aug; 38(3):213-222. PubMed ID: 31891210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel acquisitions on biology and management of transformed follicular lymphoma.
    Minoia C; Zucca E; Conconi A
    Hematol Oncol; 2018 Oct; 36(4):617-623. PubMed ID: 29602222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Dreyling M;
    Ann Oncol; 2010 May; 21 Suppl 5():v181-3. PubMed ID: 20555076
    [No Abstract]   [Full Text] [Related]  

  • 37. Rituximab maintenance versus retreatment in follicular lymphoma.
    Palla AR; Hamadani M
    Hematol Oncol; 2013 Dec; 31(4):171-8. PubMed ID: 23044794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous Disease as a Rare Presentation of Follicular Lymphoma Progression.
    Jafri H; Khan I; Khan NAJ; Graffeo V; Hawkins J; Alsharedi M
    J Investig Med High Impact Case Rep; 2021; 9():2324709621997260. PubMed ID: 33629605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recent advances in therapy of follicular lymphoma].
    Liu XX; Wang LN; Yang WL; Xi YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):250-4. PubMed ID: 24598689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs.
    Matasar MJ; Luminari S; Barr PM; Barta SK; Danilov AV; Hill BT; Phillips TJ; Jerkeman M; Magagnoli M; Nastoupil LJ; Persky DO; Okosun J
    Oncologist; 2019 Nov; 24(11):e1236-e1250. PubMed ID: 31346132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.